Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Adamas Pharmaceuticals, Inc.

TRADE

NASDAQ: ADMSHealthcare / Drugs - Generic / USA
18.68-0.35-1.84%Vol 94 5431Y Perf -1.47%
Oct 17th, 2018 13:40
BID18.64 ASK18.69
Open18.93 Previous Close19.03
Pre-Market- After-Trading19.03
 - -%  - -%
Target Price
50.50 
Analyst Rating
Strong Buy 1.25
Potencial %
169.48 
Finscreener Ranking
★★★ —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
     36.21
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)508 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
9.34 
Earnings Date
1st Nov 2018

Today's Price Range

18.5019.11

 

52wk Range

16.0744.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-4.18%
3 Months
-30.14%
6 Months
-23.91%
1 Year
-1.47%
3 Years
27.80%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADMS18.68-0.3500-1.84
AAPL221.80-0.3500-0.16
GOOG1 118.89-2.3900-0.21
MSFT110.95-0.0500-0.05
XOM81.260.06000.07
WFC54.710.98001.82
JNJ139.613.05002.23
FB159.340.56000.35
GE12.320.22001.82
JPM110.371.75001.61
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.50
Current Ratio 9.90
Long Term Debt to Total Capital 0.44
Total Debt to Equity 0.78
Interest Coverage -7.90
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin99.00
EBIT Margin-1 024.70
EBITDA Margin-1 012.00
Pre-tax Profit Margin-5 873.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.47
PS Ratios 46.23
Price to Cash Flow 23.20
Price to Free Cash Flow -6.00
Cash Flow Per Share -3.96
Price to Tangible Book3.47
Book Value per Share5.24
Enterprise Value (in ths.)402 350
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-31.75
ROE last 12 Months -97.81
Return on Assets (5Y Avg) -14.67
ROA last 12 Months -56.65
Return on Capital (5Y Avg) -1.24
ROC last 12 Months -56.58
Return on invested Capital Q -11.31
Return on invested Capital Y-42.74
Assets Turnover0.00
Receivables Turnover4.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 686
Revenue per Share 0.39
Revenue Growth 3 Years -31.82
Revenue Growth 5 Years -53.67
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-1.41-1.2610.64
Q01 2018-1.38-1.352.17
Q04 2017-1.15-1.27-10.43
Q03 2017-1.03-1.04-0.97
Q02 2017-0.85-0.93-9.41
Q01 2017-0.72-0.720.00
Q04 2016-0.82-0.6817.07
Q03 2016-0.85-0.6622.35
Earnings Per EndEstimateRevision %Trend
9/2018 QR-1.349.46Positive
12/2018 QR-1.388.61Positive
12/2018 FY-5.377.25Positive
12/2019 FY-3.775.99Positive
Next Report Date1st Nov 2018
Estimated EPS Next Report-1.34
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume94 543
Shares Outstanding (in ths.)27 190
Trades Count571
Dollar Volume1 435 796
Avg. Volume738 380
Avg. Weekly Volume329 608
Avg. Monthly Volume576 772
Avg. Quarterly Volume555 227

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

71%29%

Bearish Bullish

49%51%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
9 (100.00 %)
9 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (12.50 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x